PROMIS NEUROSCIENCES INC. Increase (Decrease) in Deferred Compensation
PROMIS NEUROSCIENCES INC. (PMN) reported Increase (Decrease) in Deferred Compensation of -$1.40 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCompensation · last filed 2023-03-08
- PROMIS NEUROSCIENCES INC. increase (decrease) in deferred compensation for the quarter ending 2021-12-31 was -$997.96K.
- PROMIS NEUROSCIENCES INC. increase (decrease) in deferred compensation for the quarter ending 2021-09-30 was -$267.28K.
- PROMIS NEUROSCIENCES INC. increase (decrease) in deferred compensation for fiscal 2021 was -$1.40M.
| Period end | Increase (Decrease) in Deferred Compensation 3 month | Increase (Decrease) in Deferred Compensation 6 month | Increase (Decrease) in Deferred Compensation 9 month | Increase (Decrease) in Deferred Compensation 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$997.96K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | -$1.27M derived: sum of 2 quarters · filed 2023-03-08 | -$1.40M 10-K · filed 2023-03-08 | |
| 2021-09-30 | -$267.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$405.51K 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | -$138.23K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |